Effector CD4 and CD8 T Cells and Their Role in the Tumor Microenvironment

Por Hadrup, Sine, Donia, Marco, thor Straten, Per
Publicado em 2012

“Immunotherapy of cancer: present status and future promise”: Danish Cancer Society Symposium, Copenhagen, Denmark, 23rd–25th September 2013

Por Donia, Marco, Lyngaa, Rikke, Hadrup, Sine Reker
Publicado em 2014

The controversial role of TNF in melanoma

Por Donia, Marco, Kjeldsen, Julie Westerlin, Svane, Inge Marie
Publicado no Oncoimmunology (2015)

Potential use of rapamycin in HIV infection

Por Donia, Marco, McCubrey, James A, Bendtzen, Klaus, Nicoletti, Ferdinando
Publicado em 2010

Eleventh international conference on progress in vaccination against cancer (PIVAC-11), 10–13 October 2011, Copenhagen, Denmark

Por Køllgaard, Tania, van den Berg, Joost H., Donia, Marco, thor Straten, Per
Publicado em 2012

New developments in the management of advanced melanoma – role of pembrolizumab

Por Improta, Giuseppina, Leone, Isabella, Donia, Marco, Gieri, Stefania, Pelosi, Giuseppe, Fraggetta, Filippo
Publicado no Onco Targets Ther (2015)

Analysis of Vδ1 T cells in clinical grade melanoma-infiltrating lymphocytes

Por Donia, Marco, Ellebaek, Eva, Andersen, Mads Hald, Straten, Per thor, Svane, Inge Marie
Publicado em 2012

Effects of Ipilimumab on expanded tumor infiltrating lymphocytes in patients with stage IV malignant melanoma

Por Bjørn, Jon, Donia, Marco V, Andersen, Rikke, Hadrup, Sine R, Svane, Inge Marie
Publicado em 2013

Polyfunctional incompletely differentiated CD8+ T cells accumulates after adoptive transfer of tumor-infiltrating lymphocytes and establish immunological memory in patients with me...

Por Donia, Marco, Kjeldsen, Julie Westerlin, Andersen, Rikke, Westergaard, Marie Christine Wulff, Svane, Inge Marie
Publicado no J Immunother Cancer (2015)

Biological insights into BRAF(V600) mutations in melanoma patient: Not mere therapeutic targets

Por Improta, Giuseppina, Pelosi, Giuseppe, Tamborini, Elena, Donia, Marco, Santinami, Mario, de Braud, Filippo, Fraggetta, Filippo
Publicado em 2013

Tumor infiltrating lymphocyte therapy for ovarian cancer and renal cell carcinoma

Por Andersen, Rikke, Donia, Marco, Westergaard, Marie Christine Wulff, Pedersen, Magnus, Hansen, Morten, Svane, Inge Marie
Publicado no Hum Vaccin Immunother (2015)

BRAF inhibition improves tumor recognition by the immune system: Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transfer

Por Donia, Marco, Fagone, Paolo, Nicoletti, Ferdinando, Andersen, Rikke Sick, Høgdall, Estrid, Straten, Per thor, Andersen, Mads Hald, Svane, Inge Marie
Publicado em 2012

T cell therapy in combination with Vemurafenib in BRAF mutated metastatic melanoma patients

Por Borch, Troels Holz, Andersen, Rikke, Kongsted, Per, Met, Özcan, Andersen, Mads Hald, thor Straten , Per, Donia, Marco, Svane, Inge Marie
Publicado no J Immunother Cancer (2014)

Broadening the repertoire of melanoma-associated T-cell epitopes

Por Frøsig, Thomas Mørch, Lyngaa, Rikke, Met, Özcan, Larsen, Stine Kiær, Donia, Marco, Svane, Inge Marie, thor Straten, Per, Hadrup, Sine Reker
Publicado no Cancer Immunol Immunother (2015)

Natural CD4(+) T-Cell Responses against Indoleamine 2,3-Dioxygenase

Por Munir, Shamaila, Larsen, Stine Kiaer, Iversen, Trine Zeeberg, Donia, Marco, Klausen, Tobias Wirenfeldt, Svane, Inge Marie, Straten, Per thor, Andersen, Mads Hald
Publicado em 2012

Role of signal transduction and microRNAs on the immunogenicity of melanoma cells

Por Meyer, Stefanie, Handke, Diana, Mueller, Anja, Meinhardt, Anne, Jasinski-Bergner, Simon, Mages, Stephan, Bukur, Juergen, Donia, Marco, Straten, PerThor, Seliger, Barbara
Publicado no J Transl Med (2015)

PD-L1 peptide co-stimulation increases immunogenicity of a dendritic cell-based cancer vaccine

Por Munir Ahmad, Shamaila, Martinenaite, Evelina, Hansen, Morten, Junker, Niels, Borch, Troels Holz, Met, Özcan, Donia, Marco, Svane, Inge Marie, Andersen, Mads Hald
Publicado no Oncoimmunology (2016)

Adoptive cell therapy with tumor infiltrating lymphocytes and intermediate dose IL-2 for metastatic melanoma

Por Andersen, Rikke, Donia, Marco, Borch, Troels Holz, Steensgaard, Eva Ellebæk, Iversen, Trine Zeeberg, Kongsted, Per, Andersen, Mads Hald, Straten , Per thor, Svane, Inge Marie
Publicado no J Immunother Cancer (2014)

CCL22-specific T Cells: Modulating the immunosuppressive tumor microenvironment

Por Martinenaite, Evelina, Munir Ahmad, Shamaila, Hansen, Morten, Met, Özcan, Westergaard, Marie Wulff, Larsen, Stine Kiaer, Klausen, Tobias Wirenfeldt, Donia, Marco, Svane, Inge Marie, Andersen, Mads Hald
Publicado no Oncoimmunology (2016)

Enhancing therapeutic efficacy by targeting non-oncogene addicted cells with combinations of signal transduction inhibitors and chemotherapy

Por Abrams, Stephen L., Steelman, Linda S., Shelton, John G., Chappell, William, Bäsecke, Jörg, Stivala, Franca, Donia, Marco, Nicoletti, Ferdinando, Libra, Massimo, Martelli, Alberto M., McCubrey, James A.
Publicado em 2010